Over-the-counter drug · UNAPPROVED DRUG OTHER
Krx Aesthetics Biophase Molecular Night Peel NDC 84755-0005
Salicyloyl phytosphingosine 10 mg/U; Gluconolactone 100 mg/U · Cream · Topical · KRX RESOURCES SDN. BHD.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 84755-0005-1 | 8475500050184755000501 | 2 U in 1 BOTTLE (84755-0005-1)Marketed from Sep 1, 2025 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Krx Aesthetics Biophase Molecular Night Peel
- Generic name (nonproprietary)
- krx aesthetics biophase molecular night peel
- Active ingredients
- Salicyloyl phytosphingosine — 10 mg/UGluconolactone — 100 mg/U
- Dosage form
- Cream
- Route
- Topical
- Labeler
- KRX RESOURCES SDN. BHD.NDC labeler code 84755
- Product type
- Over-the-counter drug
- Marketing category
- Unapproved drug (other)
- Marketing start
- Listing expires
- Other FDA classes
- Irrigation (Mechanism)
- Identifiers
- Product ID 84755-0005_4173475d-c016-8ad3-e063-6394a90ad772SPL ID 4173475d-c016-8ad3-e063-6394a90ad772SPL set ID 3dd69bcb-3743-eb01-e063-6394a90ab7e0UNII U891J4JCNH, WQ29KQ9POT
- Pharmacologic class
- Calculi Dissolution Agent
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N484755000501followed by a unit qualifier and the quantityPackage 84755-0005-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Indications and Usage KrX Aesthetics Biophase Molecular Night Peel (PHA/LHA) is indicated for topical use as an exfoliating treatment. Helps gently resurface the skin to improve texture, clarity, and brightness. Aids in the removal of dead skin cells while promoting a smoother, more radiant complexion. Recommended for use at night as part of a skincare regimen. Not intended for use on broken or inflamed skin.
Excerpt only. Read the full label for complete information.
About NDC 84755-0005
- What is NDC 84755-0005?
- 84755-0005 is the product NDC for Krx Aesthetics Biophase Molecular Night Peel, Salicyloyl phytosphingosine 10 mg/U; Gluconolactone 100 mg/U cream, listed with the FDA by KRX RESOURCES SDN. BHD.. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Krx Aesthetics Biophase Molecular Night Peel.
- What is the active ingredient?
- Salicyloyl phytosphingosine, Gluconolactone.
- Who is the labeler?
- KRX RESOURCES SDN. BHD., NDC labeler code 84755. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Krx Aesthetics Biophase Molecular Night Peel?
- None: this is the only finished product listed under this name.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.